Literature DB >> 2455445

Comparative distribution of fibronectin and vitronectin in human breast and colon carcinomas. An immunofluorescence study.

B Loridon-Rosa1, P Vielh, C Cuadrado, P Burtin.   

Abstract

Distribution of two extracellular matrix components, vitronectin and fibronectin, was studied by immunofluorescence in 40 breast infiltrating duct carcinomas and in 15 colonic adenocarcinomas. Blood vessels, especially in peritumoral colonic submucosa, gave markedly different images after staining by antivitronectin antibody and antifibronectin serum. The former exclusively decorated the elastic laminae, whereas the latter gave a reaction much closer to the endothelium, probably localized at the basement membrane of the endothelium. Strong labeling of colonic and mammary stroma carcinomas by polyclonal antiserum against fibronectin was observed, whereas monoclonal antibody against vitronectin gave much more restricted labeling in the stroma of these tumors. In the stroma of colonic carcinomas, vitronectin was often situated in areas in which elastic fibers were visualized by orcein counterstaining. In breast stroma carcinomas it was always localized only in elastosis areas. Thus, it is likely that antivitronectin binds with glycoprotein(s) associated with elastic fibers. However, vitronectin staining also was seen in areas in which no elastic fibers were characterized by the orcein method.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455445     DOI: 10.1093/ajcp/90.1.7

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells.

Authors:  C L Gladson; D A Cheresh
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Opposing effects of collagen I and vitronectin on fibronectin fibril structure and function.

Authors:  Candace D Gildner; Daniel C Roy; Christopher S Farrar; Denise C Hocking
Journal:  Matrix Biol       Date:  2014-02-06       Impact factor: 11.583

Review 3.  Regulation of cell signalling by uPAR.

Authors:  Harvey W Smith; Chris J Marshall
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

4.  Differences in tetranectin immunoreactivity between benign and malignant breast tissue.

Authors:  L Christensen; I Clemmensen
Journal:  Histochemistry       Date:  1991

5.  Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts.

Authors:  P Pujuguet; A Hammann; M Moutet; J L Samuel; F Martin; M Martin
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

6.  Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules.

Authors:  M Vasse; D Thibout; J Paysant; E Legrand; C Soria; M Crépin
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

Review 7.  Role of urokinase receptor in tumor progression and development.

Authors:  Hyangsoon Noh; Sungguan Hong; Shuang Huang
Journal:  Theranostics       Date:  2013-06-25       Impact factor: 11.556

8.  Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact.

Authors:  Hidehiko Takigawa; Yasuhiko Kitadai; Kei Shinagawa; Ryo Yuge; Yukihito Higashi; Shinji Tanaka; Wataru Yasui; Kazuaki Chayama
Journal:  Neoplasia       Date:  2017-04-20       Impact factor: 5.715

9.  Elevated expression and altered processing of fibulin-1 protein in human breast cancer.

Authors:  L M Greene; W O Twal; M J Duffy; E W McDermott; A D Hill; N J O'Higgins; A H McCann; P A Dervan; W S Argraves; W M Gallagher
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.